Olfr1507 Inhibitors
Olfr1507 Inhibitors represent a specialized category of chemical compounds designed to target and modulate the activity of Olfr1507, which stands for Olfactory Receptor 1507. Olfr1507 is a protein-coding gene that belongs to the olfactory receptor family. These receptors are primarily expressed in the olfactory epithelium, where they play a fundamental role in detecting and distinguishing various odor molecules. Olfactory receptors like Olfr1507 are critical for the sense of smell in animals, including humans. They enable the recognition of diverse odorants in the environment, triggering specific neural responses that contribute to our ability to perceive and interpret smells.
Chemically, Olfr1507 inhibitors are designed to interact with Olfr1507, potentially influencing its odorant-binding properties or downstream signaling pathways. The olfactory system is highly complex, with numerous olfactory receptors responsible for detecting different odor molecules. Inhibiting Olfr1507 specifically can help researchers better understand the intricacies of odor detection and discrimination, as well as the neural processing of olfactory information. By studying the biochemical and functional aspects of Olfr1507 and its modulation by inhibitors, researchers can contribute to the broader field of sensory neuroscience and gain insights into the mechanisms that govern the sense of smell, potentially shedding light on how animals, including humans, perceive and respond to their olfactory environment.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Ketanserin | 74050-98-9 | sc-279249 | 1 g | $700.00 | ||
Ketanserin is a selective serotonin receptor antagonist that inhibits the 5-HT2A receptor. Olfr1507, as a G protein-coupled receptor, may have signaling pathways overlapping with serotonin receptors, and blocking these pathways can inhibit Olfr1507's signaling functions. | ||||||
Alprenolol | 13655-52-2 | sc-507469 | 50 mg | $130.00 | ||
Alprenolol is a non-selective beta-adrenergic receptor antagonist that can inhibit related GPCRs by competitive binding, which may include Olfr1507, thereby inhibiting its signaling capabilities. | ||||||
Propranolol | 525-66-6 | sc-507425 | 100 mg | $180.00 | ||
Propranolol is a beta-adrenergic antagonist that can inhibit the function of related GPCRs, such as Olfr1507, by blocking the receptor's ability to activate its associated G-proteins. | ||||||
Timolol | 26839-75-8 | sc-507468 | 100 mg | $500.00 | ||
Timolol is a beta-adrenergic blocker that can inhibit the activity of G protein-coupled receptors like Olfr1507 by preventing receptor-mediated signaling. | ||||||
Labetalol | 36894-69-6 | sc-484723 | 50 mg | $176.00 | ||
Labetalol acts as both an alpha and beta blocker and can inhibit GPCR signaling pathways, potentially including the signaling of Olfr1507. | ||||||
Carvedilol | 72956-09-3 | sc-200157 sc-200157A sc-200157B sc-200157C sc-200157D | 100 mg 1 g 10 g 25 g 100 g | $122.00 $235.00 $520.00 $979.00 $1500.00 | 2 | |
Carvedilol is a non-selective beta-adrenergic blocker with alpha-blocking activity that could inhibit Olfr1507 function by impeding related GPCR signaling mechanisms. | ||||||
Nadolol | 42200-33-9 | sc-253175 | 1 g | $180.00 | ||
Nadolol is a non-selective beta-adrenergic receptor antagonist that can inhibit the function of GPCRs such as Olfr1507 by blocking the receptors and their signaling. | ||||||
Sotalol hydrochloride | 959-24-0 | sc-203699 sc-203699A | 10 mg 50 mg | $67.00 $246.00 | 3 | |
Sotalol is a beta-blocker that can inhibit the signaling of GPCRs by blocking the receptors, which may include Olfr1507. | ||||||
Pindolol | 13523-86-9 | sc-204847 sc-204847A | 100 mg 1 g | $194.00 $760.00 | ||
Pindolol is a non-selective beta-blocker that can inhibit Olfr1507 activity by competitively binding to GPCRs and blocking signal transduction. | ||||||
Esmolol Hydrochloride | 81161-17-3 | sc-211424 | 10 mg | $149.00 | 1 | |
Esmolol is a cardioselective beta1-adrenergic blocker that can inhibit the signaling of related GPCRs, potentially including Olfr1507, by preventing G-protein activation. | ||||||